ADVM
Price:
$6.76
Market Cap:
$140.61M
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorpor...[Read more]
Industry
Biotechnology
IPO Date
2014-07-31
Stock Exchange
NASDAQ
Ticker
ADVM
According to Adverum Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Adverum Biotechnologies, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ADVM's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Adverum Biotechnologies, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Adverum Biotechnologies, Inc. (ADVM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Adverum Biotechnologies, Inc.’s Dividend Yield is less than uniQure N.V. (0%), less than Rocket Pharmaceuticals, Inc. (0%), less than Rhythm Pharmaceuticals, Inc. (0%), less than Solid Biosciences Inc. (0%), less than MeiraGTx Holdings plc (0%), less than Aerovate Therapeutics, Inc. (0%), less than Adagene Inc. (0%), less than Acrivon Therapeutics, Inc. Common Stock (0%), less than Rezolute, Inc. (0%), less than AN2 Therapeutics, Inc. (0%), less than Passage Bio, Inc. (0%), less than Absci Corporation (0%), less than Kezar Life Sciences, Inc. (0%), less than Oncternal Therapeutics, Inc. (0%), less than Kodiak Sciences Inc. (0%), less than Galmed Pharmaceuticals Ltd. (0%), less than Affimed N.V. (0%), less than Mereo BioPharma Group plc (0%), less than Homology Medicines, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Atreca, Inc. (0%), less than TCR2 Therapeutics Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $263.94M | |
0% | $1.68B | |
0% | $3.01B | |
0% | $313.01M | |
0% | $300.31M | |
0% | $54.85M | |
0% | $115.55M | |
0% | $250.26M | |
0% | $240.80M | |
0% | $30.44M | |
0% | $43.48M | |
0% | $456.50M | |
0% | $40.82M | |
0% | $11.78M | |
0% | $121.54M | |
0% | $1.94M | |
0% | $57.26M | |
0% | $664.26M | |
0% | $3.02M | |
0% | $773.92M | |
0% | $3.57M | |
0% | $58.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adverum Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adverum Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Adverum Biotechnologies, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Adverum Biotechnologies, Inc. (ADVM)?
What is the highest Dividend Yield for Adverum Biotechnologies, Inc. (ADVM)?
What is the 3-year average Dividend Yield for Adverum Biotechnologies, Inc. (ADVM)?
What is the 5-year average Dividend Yield for Adverum Biotechnologies, Inc. (ADVM)?
How does the current Dividend Yield for Adverum Biotechnologies, Inc. (ADVM) compare to its historical average?